{"name":"Antiva Biosciences","slug":"antiva-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBrcGFXMDB6Y1NUY3ktQ05Ca3prVHlpb3RuMjRTYUNteHpBRmhsYkUyVzd4OTh5NFZSZ0FoeW5pQk5INFFnSnFHcGoyaE1zSkpUSmpj?oc=5","date":"2025-08-27","type":"pipeline","source":"FirstWord Pharma","summary":"Antiva flexes upbeat early-stage results for topical HPV therapy - FirstWord Pharma","headline":"Antiva flexes upbeat early-stage results for topical HPV therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPVzN6VmY3eS1ZU2ZOenFDS0xBeWhqbFpzbjlQSEFMVEJhM2E2UVBfUC1sckJOdGttSHUyeFdrdEdYMUhNRV8zc3lZMzhNVVNQVzVRdVBYUzVZNWF0QnlFSVFjbUxEb3R4Z25JazBvbi1TMEg5cDkwTmUyNmV2N1FMVFM3c3BKV1VJX0s1d2VHcENydHNfcDFUYzVfSFRYRW5iZWc?oc=5","date":"2025-08-27","type":"trial","source":"Femtech Insider","summary":"Antiva Biosciences Reports Positive Phase 1b/2 Results for HPV Treatment - Femtech Insider","headline":"Antiva Biosciences Reports Positive Phase 1b/2 Results for HPV Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxNNHVoTDkyQnpzTHVaTHh6S1JXclhROVgzOHAxXzFXVVVlTnFiNS1hMkhaaGtoMVBacGpIZlVfcWdTcmFPN0RYeERRTDhnV01TVUM0YTdGTDZqRWZILUVHTW1XSGhqemZQdGVfVmtTSnozOFdFdWx2dkx3eV84cnlSQ051Y1RveWVPTXBEX3daTU9WYnFYMi1TT3FVZlNUaXFwbFNlTzJEbXA0X291T0VXS1JBa1Q1T19sRzJNcUNkZEozZURRQ3ZTX1JKV0gtT3VRZDBxSGxaajRzVjM2T0h5VDN6Y2sxLVg0TjJqaUlpd2FzU2JwZzBCWkhURmRQVXkxSjBvQXpjREFfMDA1cW1XSTlNSTExendlcmowc0JYYVpEcl9yNW1ydEcyZk04bDJIaW8xNllOS1p0LWlR?oc=5","date":"2025-08-27","type":"trial","source":"prnewswire.com","summary":"Antiva Biosciences Announces Positive Top-Line Results from Phase 1b/2 Study of ABI-2280 for Treatment of Cervical High-Risk Human Papillomavirus (hrHPV) Infection - prnewswire.com","headline":"Antiva Biosciences Announces Positive Top-Line Results from Phase 1b/2 Study of ABI-2280 for Treatment of Cervical High-","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOTDVwS3ZmZG9jYmtpVFhSQnBQZEVxbXZlUFZYTjBUc2lTc29ZU2U1RVVEV3FaQkxqejNyUEhwSkhnWno5bFF3VGdicWtRREJqeHEwTHNJd1dCU1ZQbEY2WTJ5Y1E4N1dFTVJIdk1SNFJPaVlUUTBzMWNnOFdYMlhqTFlpVUhBcUptcUZlaWVVdlA4WGR4aHRCT0JvN29HRGxFTmF4N3hEUm1FTjZxZ2VDUVhiTnJmVXVtTGdBazY1VDhZdVBFN2drM1d6ZzNqX0R0NTFVSDR2OW1aRC13a09Qc2NmMXU1WlU2Vi00LXZ4OVctczFCMDhoZVhNY3Q0ZXpsMzFhZVFmVkpfb3NjVE93UkdzR2lHMDhobF9aa1pJdw?oc=5","date":"2024-11-18","type":"pipeline","source":"GlobeNewswire","summary":"Human Papillomavirus Market is Projected to Boost at a - GlobeNewswire","headline":"Human Papillomavirus Market is Projected to Boost at a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPYm05TV9BcEpMVFNHQm5WWVhVNjJUOWdHQVpneUdwd3lWYzEtaG50NmtVQXBoY2Rzekc3WnBidERiSnAtQmlQaHpIWXc2VHRXTjE5dUthOFZqWVdoYnFwWUhMZ0lTRjg3WW9SbF90SjVRWE5URFJ0WDVuN1pvaXpYcUNsYzIxOG8?oc=5","date":"2024-02-27","type":"pipeline","source":"Life Science Leader","summary":"Companies To Watch: Antiva Biosciences - Life Science Leader","headline":"Companies To Watch: Antiva Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcHBrWXZpcFA3UEdqaU5VTXdnZWZrcWRFRWpyWUhWWXcyLUxYNnpRWVJqbGN1a2JEUUdPZUhvVXJ0QVdkUEwzTlFldG9MaGdtbnRxVHBLa0FSNHE4Ulprb0ZYcU9VempRdTZJMC1YRTZDRXBqRlVlSldSM0E2YzdralFkSS1lTGFKZmdsT01lRmhvVnhuTGo0LVFMcmUwcWVpS2pxbW52cUoxYkhhakc0WDVrY3Bmb3l3TGZ4bmVMMlQ?oc=5","date":"2023-10-19","type":"pipeline","source":"prnewswire.com","summary":"Antiva Biosciences Strengthens Leadership with Key New Appointments - prnewswire.com","headline":"Antiva Biosciences Strengthens Leadership with Key New Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxONm9TUEdQVy1YODd0TV93UGpCTlhzdTZSN0xCWUN4Y09zRnRXTWo2cjh3TzQ1NF9PR1QzQ0dQUmJlZmN5VWpYbDFscHZEbGo0b1B2TmE4V2xjNFlKS2VYOEVONW5RZWpzdEdfcWJOSWxESGRTSGJQTExYS0Y5X1RVRDVUV0pxd2Y5SEs3SVBsSmI?oc=5","date":"2023-04-28","type":"pipeline","source":"Fierce Biotech","summary":"BMS CEO set to leave after 8-year run—Chutes & Ladders - Fierce Biotech","headline":"BMS CEO set to leave after 8-year run—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQaG1aWVY2cTFWYmUzaUxkWFltSDNpVHZMVUxyaU9wY2piVUc0Z29VOGFNVTFaOENzNkRzcGNrNVFZZThRNnlydXgyMUloN1doWFBmRkFYUmREMU1ZdS0zNW9MV3ZHT2FfNnYwQUtkWHZ4TDhEQ0p5XzA4b1B4OE4wVUJCNkt3VXhmY1lNaFlxNGN1c2ZGZXRVRUcyMnBBdDZoRm1tcjcwTmxtT0VpTThHdXhQVV9wa1A2Nnc?oc=5","date":"2021-11-02","type":"pipeline","source":"prnewswire.com","summary":"Antiva Biosciences Closes $31 Million Series D Equity Financing - prnewswire.com","headline":"Antiva Biosciences Closes $31 Million Series D Equity Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPSlBwTVZaVnN2R0R5NVY5OGFqendwa0Iyc21kU0wwTENGRnVpSUlYaVpKVTJsRHEzTFRyekJEY2hiMnRUVVVFMUtfbURfemRqR1BZSHh5aEQzQVJRWV82N0d0dnk4T2tkUjZTUFhvcEozUTdSQmZ2VDR1NDlMeVNlUWdR?oc=5","date":"2017-05-18","type":"deal","source":"UC San Diego Today","summary":"UC San Diego VC Partner Osage Invests in Antiva - UC San Diego Today","headline":"UC San Diego VC Partner Osage Invests in Antiva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1uN2R3LUxyenhPQjZqc0RvTmZEaVNwNmQ3dzB2UHBzVmx1NEs0RjRUcHhXcWxHZk9VcnN0NHF2MWlLRFFZY3BFTXVWa244VUNzZjZXakJubW9CU2stSHFWTVZMcTlhYTZJZ1hqUXplZG9EQQ?oc=5","date":"2014-11-28","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"30 Top VC Firms for Biotechs - Genetic Engineering and Biotechnology News","headline":"30 Top VC Firms for Biotechs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}